From Silent Atrocities to Justice: Examining the Legal Landscape of Forced Sterilisation of Women with Disabilities across Europe
By Shivam Jadaun and Shivani,
JURISTnews
| 06. 27. 2024
Image by European Council from Flickr
In some European Union nations, the forced sterilisation of people with disabilities is still a widespread and concerning practice that blatantly violates their fundamental rights and human dignity. The scope of forced sterilisation in the EU was discovered through a study carried out by the European Disability Forum. At least 14 EU members still engage in the practice, with three of them Czechia, Hungary, and Portugal explicitly allowing it on children despite worldwide criticism and established legal frameworks which prohibits forced sterilisation such as United Nations Convention on the Rights of Persons with Disabilities, which is ratified by the EU and all its Member States, and It is also forbidden under the Council of Europe Convention on preventing and combating violence against women and domestic violence (‘Istanbul Convention’). Only nine EU nations forbid forcible sterilisation.
Moreover, The United Nations Convention on the Rights of Persons with Disabilities (“UNCRPD”), lacks explicit mention of forced sterilisation in treaty text, but the Committee on the Rights of Persons with Disabilities has gone on to emphasise protection...
Related Articles
By Vittoria Vardanega, SWI swissinfo.ch | 02.13.2026
In recent years, sperm donation has produced family trees of unprecedented size, stretching across countries and, in some cases, continents. Stories of “mass donors” have captured public attention, most recently through the Netflix documentary series, The Man with 1,000 Kids...
By Jonathan D. Moreno, Hastings Center Bioethics Forum | 02.09.2026
When I began to write a book about bioethics and the rules-based international order, the idea that the world was facing the greatest geopolitical change since World War II was uncontroversial for those who were paying attention to such esoterica...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...